JDA, BCRX and AKRX Biggest Small-Cap Winners in Late RallyStocks closed up today in trading that dipped downward for most of the trading session only to crawl back up in the afternoon. The Dow was up 68 points to close at 8,916; the Nasdaq inched up in late trade to post a 7 point gain and close at 1,916; and the S&P 500 close at 955, up just over 3 points. Small-cap gainers were lead by JDA Software Group (Nasdaq:JDAS) of Scottsdale, Arizona, up 34% today after the company's second quarter earnings beat Wall Street projections handily. JDA makes software that helps retailers manage their inventories and as those retailers have been looking to improve their bottom lines by minimizing stock in inventory they've turned to JDA for help. According to Thomson Reuters the street was looking for profits of 30 cents per share while the firm reported 47 cents per share. Other small-cap gainers include BioCryst Pharmaceuticals (Nasdaq:BCRX) up 22%; and Akorn (Nasdaq:AKRX) up 17%. Leading percentage decliners for the day include Headwaters (NYSE:HW) down 23%; CIT Group (NYSE:CIT) down 22%; and LexMark International (NYSE:LXK) down 20%. Ian Wyatt
CIT Group Avoids BankruptcyStocks extended last week's rally on news the troubled lender CIT Group (NYSE:CIT) should be able to avoid bankruptcy. (More about CIT below.)
The Dow closed up 104 points to end the day at 8,848; the Nasdaq was up 23 points to finish at 1,909; and the S&P 500 topped 950 to close at 951, up nearly 11 points.
The Russell 2000 closed at 527, up nearly 8 points.
Leading small-cap gainers include ValueVision Media (Nasdaq:VVTV) up 30%; Orexigen Therapeutics (Nasdaq:OREX) up 27% on news that its experimental weight-loss drug, Contrave, had exceeded FDA benchmarks for demonstrating clinically significant weight loss among its test subjects; and Dana Holding Corporation (NYSE:DAN) up 22%. Small-cap decliners were lead by Infinera Corporation (Nasdaq:INFN) down 19% after being downgraded to Underperform from Hold by Jefferies & Co. Other small-cap decliners include Harman International Industries (NYSE:HAR) down 17% on a company denial that it had received a bid to be purchased by a middle eastern investment fund; and Mesabi Trust (NYSE:MSB) down 15%.*****It was a busy weekend. First and foremost on my mind is the ""almost was" story of Tom Watson at the British Open. I can honestly say I was crushed when it wasn't the 59-year old Watson holding up the Claret Jug when the tournament was done.
Watson fought so hard, and played so well. To not win seemed unfair. But that's golf. Still, it was a great story while it lasted. Bravo, Mr. Watson. *****The government was busy too. Five more banks failed over the weekend -mostly small regional banks that aren't making many headlines. *****CIT Group (NYSE:CIT) was saved by a $3 billion lifeline from its bondholders. This is big news for the nation's retailers as CIT is one of the biggest lenders to small retailers in the U.S. Even though CIT was denied more bailout money, it's significant that investors were willing to support the troubled company. At some point, the government has to back off with the bailouts if it really believes the economy is improving. And if the economy is improving, private investors should be willing and able to move on troubled companies. Both of these things happened with CIT. And that's helped the stock, and the stock market, post gains in the early going Monday. *****Goldman Sachs (NYSE:GS) is upping its year-end target for the S&P 500 to 1,060. That's about 120 points higher than current levels. Goldman believes that rising corporate earnings will support higher stock prices. We've seen earnings beat analyst expectations so far this earnings season. And there have been a few companies offering higher forecasts. But most companies have achieved better earnings through cost-cutting, not growing revenues. Cost-cutting cannot give permanent increases to earnings. At some point, revenues must rise. The markets are rallying on earnings. But it will take evidence of rising revenues to sustain the rally. *****Now, let's have a look at the week ahead. Of course, earnings will dominate the news once again with reports from Legg Mason (NYSE:LM) and Texas Instruments (NYSE:TXN) this afternoon. Tomorrow, we get Apple (Nasdaq:AAPL), Caterpillar (NYSE:CAT), and Coca-Cola (NYSE:KO). Wednesday, it's Morgan Stanley (NYSE:MS), US Bancorp (NYSE:USB) and Wells-Fargo (NYSE:WFC) plus a host of regional banks. Thursday is a huge day. We'll hear from 3M (NYSE:MMM), AT&T (NYSE:T), Microsoft (NYSE:MSFT), American Express (NYSE:AXP), UPS (NYSE:UPS), McDonald's (NYSE:MCD) and Amazon.com (Nasdaq:AMZN), just to name a few. Then Friday, things lighten up with Black & Decker (NYSE:BDK) and Ingersoll-Rand (NYSE:IR) reporting. On the economic front, we get crude inventories on Wednesday, July 22. Then Thursday, July 23, it's initial jobless claims and existing home sales. And finally on Friday, July 24, we get the Michigan Consumer Sentiment Review.
CIT Tumbles 75% on No BailoutStocks close up today after most of today's trading was tightly range bound. The Dow soared to 8,730 from 8,607 around The Nasdaq showed an even greater percentage gain (1.19% v. 1.11%) to close up 22 points and finish the day at 1,885. The S&P 500 closed at 940, up 8 points on the day. The Russell 2000 was 7 points to close at 523. The volume leader in the small-cap space include Small-cap gainers were lead by ARCA biopharma (Nasdaq: That was a terrific rally yesterday. Intel's (Nasdaq:INTC) earnings truly were a surprise. We've now seen the two biggest up days in 6 weeks come on consecutive days. The major indices had been looking weak, but not anymore. JP Morgan (NYSE:JPM) is the latest company to beat earnings expectations. But let's not forget that it's widely believed that analysts really low-balled the company earnings estimates across the board for the 2nd Quarter, so companies should be besting them. *****China's 2nd Quarter GDP number is out. The country grew at 7.9%, and may hit 10% by the 4th Quarter. Industrial production and fixed asset investment grew strongly. Several banks upped their growth forecasts for China today. (If you're interested in tapping into the run-up in China stocks, check out my new report. Click here for your copy.) *****Despite all the good news this morning, the chinks in the armor are clear to see. The number of households facing foreclosure was up 15% in the first half of the year. As many 336,000 homeowners received a foreclosure notice in June. Year over year, foreclosure filings were up 33% in June. And they were up 5% just since May. Foreclosures are on the rise despite the government's $50 billion program to assist loan modifications for troubled mortgage holders. This will no doubt weigh heavily on banks that still have outsized exposure to the sub-prime market and reinforces our strategy of looking for investment opportunity outside the housing and financial sectors, JPM and GS notwithstanding.
INTC and GCI Earnings Drive Stocks Higher in Wednesday TradingStocks jumped today after consecutively back to back good reports from Goldman Sachs (NYSE:GS) and Intel (Nasdaq:INTC) as well as a surprise from Gannett (NYSE: Good news kept flowing as investors were treated to revisions from the Federal Reserve Open Market Committee that the economy will shrink from 1% to 1.5% in 2009 as opposed to its earlier prognostication of 1.3% to 2%. The committee raised its inflation projection for 2010 to a range of 1.2% to 1.8%. The Dow was up sharply by 256 points to close at 8,616, the highest its been in a month. The Nasdaq closed up 63 points to 1,863 and the S&P 500 roared to 933, up 27 points from yesterday's close at 906. Small-cap stocks fared well with the Russell 2000 closing at 509, up 15 points. Today's volume leaders in the small-cap space include yesterday's leader, Small-cap gainers were lead by Targacept (Nasdaq:TRGT) up 137% after news broke that its depression treatment drug candidate, currently called TC-5214, was able to significantly outperform a placebo drug in testing on patients with major depression disorders. The company announced that it expects to start late-stage trials of the drug in Q2 2010 and is in talks with several potential partners to help complete the drug's development. Other small-cap gainers include a one-time holding with SmallCapInvestor PRO, Brigham Exploration (Nasdaq: *****If you've ever wondered what it's like to be Warren Buffett and have more cash than you can spend or invest, just ask China. China just announced that it has over $2 trillion in foreign reserves. Ian Wyatt Newsletter Advisors Wednesday This week's NewsletterAdvisors.com investment expert is Andy Obermueller, Chief Investment Strategist and editor for StreetAuthority's Government-Driven Opportunities. Andy was a journalist before joining StreetAuthority. He worked for the business desks of the Philadelphia Inquirer and the Star-Ledger, New Jersey's largest paper, before going on to lead business coverage for a Texas daily. Andy briefly left the industry to get an inside look at corporate finance as a commercial lender for Wells Fargo's business banking group. He lives in Austin. Andy, thanks for joining us today, now let's get started. Can you explain your investment process and criteria for investments? For instance, the FDA is part of the Department of Health and Human Services. I have a database of every drug in the approval process. For some giant drugmakers -- a Merck, say, or a Pfizer -- a new drug might not have much impact on the bottom line. But when the government approves a drug for a smaller drugmaker, the effect is huge. Those small drugmakers can be extremely lucrative investments -- all because of a government action. What do you believe gives the government-driven investment style an edge over other investment styles? Look, I'm passionate about this topic for one reason: it works. I've personally invested using a number of strategies over the years. Like you, I've tried various combinations of value, income and growth strategies. However, I'm not sure I've ever seen anything with as much potential as the government-driven stocks I'm finding. What sectors do you think offer the most opportunities to profit from government action today? Ok, let's look at energy. Tell me about a government-driven stock you've dug up in this area. Well, everyone knows that clean energy is a major part of the Obama agenda. He hasn't even been in office a year yet and his green initiatives are already playing out. On June 28th the House passed the "cap-and-trade" bill - which calls for a dramatic reduction in the amount of CO2 that industry can emit. This is historic. The problem is, 35% of America's carbon emissions come from coal-fired power plants. Why? Because coal is both abundant and cheap in the U.S. -- we're sitting on enough of the stuff to power every home in America for the next 400 years. And at the same time, these coal plants are simply too expensive to replace. It would take $672 billion and several years. But 'cap and trade' is a major thorn in the side of coal. The only solution I see is to find a way to burn coal without producing CO2. A handful of companies have actually figured out how to do this. Their method, called oxy-coal, is recognized as being perhaps the most promising environmentally-friendly technology on the planet. My favorite pick in this area is Praxair (NYSE:PX). It owns more than 200 patents related to oxy-coal. What are your top three stock recommendations, and what attracts you to each? Next I like Energy Recovery (Nasdaq:ERII). It makes a device that's critical to the efficiency of large desalinization plants, which are typically owned by governments. Without its equipment, desalinization is cost-prohibitive. ERII has 70% of the worldwide market, which is expected to double in the next ten years as water becomes ever scarcer. This issue is a lot closer to home than most people realize: Water supplies aren't just critical in the Middle East, they're increasingly important in places like California. Finally, I like several players in the digital medical records space. The stimulus bill provides for $19 billion for these companies to upgrade the way the health-case system stores patient information. Storing these files digitally will improve physician access to information and not only improve the quality of care but reduce its cost, such as by eliminating unnecessary and potentially redundant medical tests. Among my recommendations here is Quadramed (NYSE:QDHC), which helped the Veterans Administration develop its VistA Program, the first and most successful large-scale electronic medical records system. Andy, thanks for the insights on how to profit from government spending and for the recommendations you're following. I'm sure readers will want to follow-up on those. This is certainly an exciting time to invest in companies making billions off the federal government. Andy Obermueller is the Chief Investment Strategist for StreetAuthority's Government-Driven Investing newsletter. Andy invites you to follow his Government-Driven Investing blog, where he publishes his investing insights for free, at http://www.Government-DrivenInvesting.com
CIT, AIG, and DRYS Lead Small-Cap Volume in Seesaw Trading SessionStocks moved in a seesaw pattern today as they opened high and then slid during the opening hours only to sharply pick up before noon eastern time. Shares on the Dow closed up 28 points to end the day at 8,359. The Nasdaq finished up 7 points to close at 1,800 and the S&P 500 was up almost 5 points to close at 906. The Russell 2000, an index of the 2,000 most influential small-cap stocks as determined by Russell Investments, closed the day's trading session at 496, up 3 points. Price gainers in the small-cap space were lead by Nevsun Resources (AMEX:NSU) up 32% following news that it had received all approvals for debt facilities totaling $235 million to begin mining copper and gold in Eritrea. The Vancouver-based mining firm expects to be able to repay the entire debt within two and one-half years. Other small-cap gainers include Noven Pharmaceuticals (Nasdaq:NOVN) up 22% on news that Japan-based Hisamitsu Pharmaceutical plans to increase its U.S. presence in purchasing the company for $16.50 a share; Excel Maritime Carriers (NYSE:EXM) up 21%; and CIT Group (NYSE:CIT) up 20%. I'm referring to Goldman's 2nd Quarter earnings blowout. Goldman beat revenue and earnings estimates by better than 30%. Clearly, just like the sluggers in the homerun derby, Goldman had softball pitches thrown right down the center of the plate to hit. Don't forget that even the bears' best friend, bank analyst Meredith Whitney, turned bullish on Goldman yesterday. It would appear that she could see the writing on the wall - analyst estimates were simply too low. But why? How could analysts miss Goldman's quarter by such a wide margin? Could it be that they are deliberately low-balling estimates to keep the rally going? *****Goldman Sachs is up in the early going, but not as much as you might expect. That suggests that the blowout numbers aren't a surprise at all. It was already priced in during Monday's 10% rally. This type of behavior from analysts puts individual investors in a difficult position. I suspect that buyers above $150 will be showing a loss in the near future. Once again, we are being suckered. And that's business as usual for Wall Street. *****If you focus on the gain in the Producer Price Index (PPI) from this morning, you're probably thinking that inflation is on its way after prices rose 1.8% in June. But if you focus on retail sales, you probably see the 0.6% rise in retail sales as a sign of recovery. So which is it: inflation or recovery? The answer is: both. Inflation is an inevitable by-product of economic expansion. Now, obviously, the U.S. economy is still playing catch-up. And there's an outside possibility that the economy will grow this quarter. But the most important thing to realize is that both the retail sales number and the PPI number are almost directly related to government actions. If you exclude auto and gasoline sales, retail sales actually fell for a fourth straight month. Auto sales have been helped by government incentives to trade in a gas guzzling clunker for a new, more efficient vehicle. The PPI was affected by another government incentive program - the yield on Treasury bills. As the Treasury sells more and more bonds, it has to offer a higher yield to entice buyers. This, along with the sheer amount off Treasuries that are being sold, is driving the value of the U.S. dollar down. That, in turn, is driving oil and gas prices higher. Without food and energy, the PPI only rose 0.5%. *****Government actions are currently filling in for an actual economy. That's how it is in our new "Managed America." Most expect the heavy hand of government to be temporary, and that Managed America can end sooner than later. We'll see… I expect the conditions of Managed America - high unemployment, sluggish growth, more regulations, higher taxes, and inflation to last years instead of months. And I've outlined my expectations for investing under these conditions in my new Special Issue of Top Stock Insights. The article is titled Managed America: The New Economic Reality. It will be released tomorrow. You can sign up for Top Stock Insights and get my blueprint for profiting in Managed America when you click here. You'll also be on the list to receive my Predictions 2009 Issue update for the remainder of this year.
Small caps rally 1.39%; CIT, TNH and ES lead gainers
The Russell 2000 1.39% today, notching the sixth consecutive daily gain -- something that hasn’t happened all year. Today's small-cap gainers were CIT Group (NYSE:CIT), Terra Nitrogen (NYSE:TNH) and EnergySolutions (NYSE:ES).
[ More » ]
Other Market Watch highlights included:
Small caps down 1.89% at close, CIT, USAP and ABK lead gainersSmall-cap stocks slipped 1.89% late Friday, as a bleak report on the housing sector, options expiration volatility and ongoing worries about the economy offset a spate of positive earnings in the tech arena. Today’s small-cap gainers are CIT Group (NYSE:CIT), Universal Stainless & Alloy Products (Nasdaq:USAP) and Ambac Financial Group (NYSE:ABK). Other Market Watch highlights today included: • BMO Capital's Andy Busch to SCI: "There is a serious need to educate the banking sector participants on the changes in the Treasury programs the Fed programs directed at easing the credit crunch."
Russell slightly lower; UAUA, CIT and AKT lead gainersThe Russell 2000 (NYSE:IWM) remained a smidge lower into the midday, but well off the morning lows as gains in the technology arena spilled over into the broad market. Concerns about the economy, a moribund housing market and expiration jitters kept a lid on some buying interest, but the market was trying to spark a rally heading toward the afternoon. Today’s small-cap gainers are UAL Corp. (Nasdaq:UAUA), CIT (NYSE:CIT) and Ambac Financial Group (NYSE:AKT). Other Market Watch highlights today include: • Light, sweet crude for November delivery is up $1.66 to $71.51 a barrel. On Thursday, it sank to a 14-month low on worries about a deep global recession obliterating fuel demand. Small Cap Gainers: • CIT (NYSE:CIT) loss widens; vendor finance write-down hurts. Shares of the finance company are soaring 47%. spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer
|
|